leukocidin


Also found in: Dictionary, Medical, Wikipedia.

leukocidin

[‚lü·kə′sīd·ən]
(biochemistry)
A toxic substance released by certain bacteria which destroys leukocytes.
References in periodicals archive ?
Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes.
Daum, "Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin," Laboratory Investigation, vol.
Eggimann, "Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports," Annals of Intensive Care, vol.
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.
aureus isolates were tested for the Panton-Valentine leukocidin (PVL) genes, methicillin resistance gene (mecA), and staphylococcal protein A (spa) gene as previously described [17].
aureus) strains isolated from bovine mastitis, presence / absence of virulence genes such as Panton-Valentine leukocidin (PVL), g-hemolysis and LukED and quantitative analysis were conducted by Real-Time PCR.
A probe-based method for confirmation of methicillin-resistant Staphylococcus aureus and detection of Panton-Valentine leukocidin and tst virulence genes.
Panton Valentine leukocidin in MRSA strains isolated from patients at the University Hospital of Maracaibo
The S.aureus was found to be Panton-Valentine leukocidin (PVL) cytotoxin gene positive by the PVL PCR assay.
aureus isolates also produce one or more additional exoproteins, such as toxic shock syndrome toxin-1 (TSST-1), staphylococcal enterotoxins (SEs), exfoliative toxins (ETs), and leukocidins. (2-4) Recently, Panton-Valentine leukocidin (pul) encoded by two contiguous and cotranscribed genes (lukS-PV and lukF-PV) is an important virulence factor for community-acquired MRSA (CA-MRSA) affecting individuals without apparent risk factors for hospital acquisition.